Cargando…

Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectiveness

BACKGROUND: The control of tuberculosis (TB) in India is complicated by the presence of a large, disorganised private sector where most patients first seek care. Following pilots in Mumbai and Patna (two major cities in India), an initiative known as the ‘Public–Private Interface Agency’ (PPIA) is n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arinaminpathy, Nimalan, Nandi, Arindam, Vijayan, Shibu, Jha, Nita, Nair, Sreenivas A, Kumta, Sameer, Dewan, Puneet, Rade, Kiran, Vadera, Bhavin, Rao, Raghuram, Sachdeva, Kuldeep S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493898/ https://www.ncbi.nlm.nih.gov/pubmed/34610905 http://dx.doi.org/10.1136/bmjgh-2021-006114

Ejemplares similares

Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales data
por: Arinaminpathy, Nimalan, et al.
Publicado: (2019)

What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in India
por: Deo, Sarang, et al.
Publicado: (2019)

Modelling the impact of effective private provider engagement on tuberculosis control in urban India
por: Arinaminpathy, Nimalan, et al.
Publicado: (2019)

The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis
por: Arinaminpathy, Nimalan, et al.
Publicado: (2020)

Predicting the impact of patient and private provider behavior on diagnostic delay for pulmonary tuberculosis patients in India: A simulation modeling study
por: Deo, Sarang, et al.
Publicado: (2020)

The number of privately treated tuberculosis cases in India: an estimation from drug sales data
por: Arinaminpathy, Nimalan, et al.
Publicado: (2016)

Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis
por: Nair, Sreenivas Achuthan, et al.
Publicado: (2016)

The Potential Impact of Up-Front Drug Sensitivity Testing on India’s Epidemic of Multi-Drug Resistant Tuberculosis
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2015)

The potential impact of vaccination on tuberculosis burden in India: A modelling analysis
por: Arinaminpathy, Nimalan, et al.
Publicado: (2023)

STEPS – a patient centric and low-cost solution to ensure standards of TB care to patients reaching private sector in India
por: Rakesh, P. S., et al.
Publicado: (2022)

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2015)

Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007–2011): Evidence leading to policy enhancement
por: Parmar, Malik M., et al.
Publicado: (2018)

Cost of TB services in the public and private sectors in Georgia
por: Chikovani, I., et al.
Publicado: (2021)

Trade-offs between cost and accuracy in active case finding for tuberculosis: A dynamic modelling analysis
por: Cilloni, Lucia, et al.
Publicado: (2020)

Costing electronic private sector malaria surveillance in the Greater Mekong Subregion
por: Levin, Ann, et al.
Publicado: (2021)

Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis
por: Silva, Sachin, et al.
Publicado: (2021)

Adaptations to the first wave of the COVID-19 pandemic by private sector tuberculosis care providers in India
por: Mannan, Shamim, et al.
Publicado: (2022)

Economic costs of childhood stunting to the private sector in low- and middle-income countries
por: Akseer, Nadia, et al.
Publicado: (2022)

Colorectal Cancer (CRC) treatment and associated costs in the public sector compared to the private sector in Johannesburg, South Africa
por: Herbst, Candice-lee, et al.
Publicado: (2020)

Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2022)

Feasibility of Decentralised Deployment of Xpert MTB/RIF Test at Lower Level of Health System in India
por: Raizada, Neeraj, et al.
Publicado: (2014)

Delivering hypertension care in private-sector clinics of urban slum areas of India: the Mumbai Hypertension Project
por: Hegde, Asha, et al.
Publicado: (2022)

Enhancing TB Case Detection: Experience in Offering Upfront Xpert MTB/RIF Testing to Pediatric Presumptive TB and DR TB Cases for Early Rapid Diagnosis of Drug Sensitive and Drug Resistant TB
por: Raizada, Neeraj, et al.
Publicado: (2014)

Case fatality and recurrent tuberculosis among patients managed in the private sector: A cohort study in Patna, India
por: Huddart, Sophie, et al.
Publicado: (2021)

Can rising labor costs boost private sector R&D investment? : Evidence from a survey of Chinese private firms
por: Deng, Chuyao, et al.
Publicado: (2022)

Pharmacy-based dispensing of antimicrobial agents without prescription in India: appropriateness and cost burden in the private sector
por: Shet, Anita, et al.
Publicado: (2015)

Applying a private sector capitation model to the management of type 2 diabetes in the South African public sector: a cost-effectiveness analysis
por: Volmink, Heinrich C, et al.
Publicado: (2014)

Catching the Missing Million: Experiences in Enhancing TB & DR-TB Detection by Providing Upfront Xpert MTB/RIF Testing for People Living with HIV in India
por: Raizada, Neeraj, et al.
Publicado: (2015)

Dynamics of Glycoprotein Charge in the Evolutionary History of Human Influenza
por: Arinaminpathy, Nimalan, et al.
Publicado: (2010)

Cost of hemodialysis in a public sector tertiary hospital of India
por: Kaur, Gunjeet, et al.
Publicado: (2018)

Health impact and cost-effectiveness of a private sector bed net distribution: experimental evidence from Zambia
por: Sedlmayr, Richard, et al.
Publicado: (2013)

Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors
por: Subramanian, Sujha, et al.
Publicado: (2018)

The cost-effectiveness of incentive-based active case finding for tuberculosis (TB) control in the private sector Karachi, Pakistan
por: Hussain, Hamidah, et al.
Publicado: (2019)

Financial implications of protocol-based hypertension treatment: an insight into medication costs in public and private health sectors in India
por: Sahoo, Swagata Kumar, et al.
Publicado: (2022)

New Vision for Revised National Tuberculosis Control Programme (RNTCP): Universal access - “Reaching the un-reached”
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2012)

High Diabetes Prevalence among Tuberculosis Cases in Kerala, India
por: Balakrishnan, Shibu, et al.
Publicado: (2012)

TB case fatality and recurrence in a private sector cohort in Mumbai, India
por: Huddart, S., et al.
Publicado: (2021)

Voluntary medical male circumcision service delivery in South Africa: The economic costs and potential opportunity for private sector involvement
por: Tchuenche, Michel, et al.
Publicado: (2018)

Correction to: The cost-effectiveness of incentive-based active case finding for tuberculosis (TB) control in the private sector Karachi, Pakistan
por: Hussain, Hamidah, et al.
Publicado: (2019)

Modelling the cost-effectiveness of introducing subsidised malaria rapid diagnostic tests in the private retail sector in sub-Saharan Africa
por: Bath, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1ph0k4h7auj2mahomd83n10smr